Vir Biotechnology Inc (VIR)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,588,230 | 2,519,080 | 1,562,820 | 772,365 | 402,995 |
| Total current liabilities | US$ in thousands | 175,407 | 511,029 | 341,242 | 99,064 | 59,206 |
| Current ratio | 9.05 | 4.93 | 4.58 | 7.80 | 6.81 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,588,230K ÷ $175,407K
= 9.05
The current ratio of Vir Biotechnology Inc has shown fluctuations over the past five years. As of December 31, 2023, the current ratio stands at 9.05, indicating a significant increase compared to the previous year. This suggests that the company has substantially more current assets relative to its current liabilities, reflecting a strong liquidity position.
However, it is important to note that the current ratio was lower in 2022 and 2021, at 4.93 and 4.58 respectively. This could indicate a potential liquidity concern in those years, which may have improved by the end of 2023. The ratios for 2020 and 2019 were 7.80 and 6.81 respectively, showing relatively good liquidity positions in those years as well.
Overall, the current ratio of Vir Biotechnology Inc has experienced fluctuations, but the significant increase in 2023 suggests improved liquidity and the ability to meet short-term obligations comfortably.
Peer comparison
Dec 31, 2023